Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

SANOFI VACCINES US INC.

Subsidiary ofSANOFIUEI: NCXBGGQ8YTU9CAGE: 7V915

SANOFI VACCINES US INC. is a federal contractor, registered under UEI NCXBGGQ8YTU9 and CAGE code 7V915. It has been awarded $18,083,615,000 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing, Pharmaceutical Preparation Manufacturing, and Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Health And Human Services, Department Of Defense, and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

NCXBGGQ8YTU9

CAGE Code

7V915

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325414Biological Product (except Diagnostic) Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Sanofi Pasteur Inc. specializes in the manufacturing of biological products and pharmaceutical preparations, with deep expertise in vaccine development, sterile biologic production, and the supply of specialized medical therapeutics. The company’s technical capabilities center on GMP-compliant manuf...

Sanofi Pasteur Inc. specializes in the manufacturing of biological products and pharmaceutical preparations, with deep expertise in vaccine development, sterile biologic production, and the supply of specialized medical therapeutics. The company’s technical capabilities center on GMP-compliant manufacturing processes for injectable biologics, including polysaccharide conjugate vaccines and other immunobiological agents, supporting both domestic and international public health initiatives. Their operational focus includes aseptic processing, cold chain logistics, and regulatory-compliant packaging, ensuring product integrity for mission-critical applications. While not certified under federal small business programs, the company leverages decades of industry experience in high-containment biomanufacturing and quality systems aligned with FDA and WHO standards. The contractor maintains consistent engagement with the Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs, primarily supplying vaccines and medical countermeasures for military readiness, veteran health programs, and public health preparedness. The Department of State also routinely procures medical supplies through the company, indicating support for overseas diplomatic health missions and global health security efforts. Primary industry focus lies in NAICS 325414 for biological product manufacturing and 325412 for pharmaceutical preparation, positioning the firm as a trusted producer of non-diagnostic biologics for government health and defense needs. The company’s market role is that of a mission-critical supplier of life-saving therapeutics, with specialization in vaccines and immunobiologics requiring stringent stability and sterility controls. Based in Swiftwater, Pennsylvania, Sanofi Pasteur Inc. operates as a large-scale manufacturing entity with no active small business certifications. Its geographic presence is anchored in U.S.-based production facilities supporting federal supply chains, with distribution networks enabling delivery to domestic and international government recipients.

Key Performance Metrics

Awards Count

7,938

All time

Active

53

Currently performing

Completed

7,882

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
Awards by Agency Over Time
Awards by Place of Performance

Compete with SANOFI VACCINES US INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for SANOFI VACCINES US INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in SANOFI VACCINES US INC.'s top NAICS codes and agencies

NAICS: 325412
New
Federal
Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals
Solicitation # NOI-OD-27-000001
The National Institutes of Health Clinical Center, specifically the Nuclear Medicine Division within the Department of Radiology and Imaging Sciences, has issued a Notice of Intent to Sole Source for the procurement of FDA-approved radiopharmaceuticals. The anticipated purchase order value is not to exceed 900,000 dollars. This acquisition is being conducted under FAR Part 13 Simplified Acquisition Procedures, Subpart 13.500, which allows for simplified procedures for commercial products and exempts the procurement from FAR Part 6 competition requirements. Cardinal Health 414, LLC is identified as the sole acceptable vendor due to their 25-year history of reliability and their unique ability to provide a comprehensive range of radiopharmaceuticals emitting gamma, positron, beta, and alpha radiations. Additionally, the vendor utilizes a patented tungsten delivery system for high energy positron radiopharmaceuticals, which is required to minimize radiation exposure to staff and the public while adhering to safety weight standards. This action is a notice of intent only; no solicitation document will be issued and no quotations will be requested. Comments regarding this notice, referencing solicitation number NOI-OD-27-000001, must be submitted to Contract Specialist Ryssa Nix by October 19, 2026, at 12pm EST.
National Institutes Of Health Olao

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0084
Solicitation SPE2DP-27-T-0084, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of five cases of fruit punch flavored electrolyte oral hydration powder. Each case contains 100 packets of 21 grams each, providing sodium, potassium, chloride, citrate, magnesium, zinc, 16 grams of carbohydrates, and 65 calories per packet. This FDA-regulated product requires reconstitution with water and has an extendable shelf life of 60 months. The requirement is identified by NSN 6505-01-731-1586 and is associated with Drip Drop Hydration Inc. Delivery is required within five days of order, with an original required delivery date of October 13, 2026. Shipping is FOB Destination to locations in Norman and Oklahoma City, Oklahoma, using the fastest traceable means. Packaging must be commercial and adhere to MIL-STD-2073-1E and DLA requirement RP001, while marking must comply with Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons. Invoicing must be processed electronically through the Wide Area WorkFlow system. Quotations are due by October 19, 2026, and must include all necessary representations and certifications, specifically regarding small business status and domestic material disclosure.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
FERRIC SUBSULFATE S
Solicitation # SPE2DP-27-T-0086
Solicitation SPE2DP-27-T-0086 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Ferric Subsulfate Solution, Monsels. The requirement is for three packages, with each package containing twelve 8 ml bottles. This medical product is intended for direct application to surgical sites following the excision of diseased tissue. Critical storage restrictions prohibit the use of aluminum, carbon steel, copper, copper alloys, zinc, or nickel. The item is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Delivery is required within 20 days after order, with the original required delivery date set for April 9, 2026. The shipping terms are FOB Destination, with delivery points located at APO AE 09126-3865 and Flugplatz Spangdahlem, Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Because the material is hazardous, the contractor must provide a Material Safety Data Sheet and ensure labeling complies with the Hazard Communication Standard 29 CFR 1910.1200. The contract incorporates several key Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including those regarding the Buy American and Balance of Payments Program, safeguarding covered defense information, and combating trafficking in persons. Inspection and acceptance will occur at the destination. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system. Offerors are identified under NAICS code 325412 and must provide necessary small business representations and certifications.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details